MAGEA4

Last updated
MAGEA4
PDB 1i4f EBI.jpg
Available structures
PDB Human UniProt search: PDBe RCSB
Identifiers
Aliases MAGEA4 , CT1.4, MAGE-41, MAGE-X2, MAGE4, MAGE4A, MAGE4B, MAGE family member A4
External IDs OMIM: 300175 HomoloGene: 134073 GeneCards: MAGEA4
Orthologs
SpeciesHumanMouse
Entrez
Ensembl
UniProt
RefSeq (mRNA)

NM_001011548
NM_001011549
NM_001011550
NM_002362

n/a

RefSeq (protein)

NP_001011548
NP_001011549
NP_001011550
NP_002353

n/a

Location (UCSC) Chr X: 151.91 – 151.93 Mb n/a
PubMed search [2] n/a
Wikidata
View/Edit Human

Melanoma-associated antigen 4 is a protein that in humans is encoded by the MAGEA4 gene. [3] [4]

Contents

This gene is a member of the MAGEA gene family. The members of this family encode proteins with 50 to 80% sequence identity to each other. The promoters and first exons of the MAGEA genes show considerable variability, suggesting that the existence of this gene family enables the same function to be expressed under different transcriptional controls.

Clinical importance

The MAGEA genes are clustered at chromosomal location Xq28. They have been implicated in some hereditary disorders, such as dyskeratosis congenita. At least four variants encoding the same protein have been found for this gene. [4]

In salivary gland carcinomas, MAGE4 expression correlates to lower-grade histology, lower likelihood of metastases and more favourable survival. [5]

While MAGEA4 is expressed by many tumours, [6] it is almost universally expressed by synovial sarcomas. [7] A targeted treatment to use genetically modified autologous T cells is (as of June 2021) undergoing clinical trials. [8]

Related Research Articles

<span class="mw-page-title-main">Clusterin</span> Protein-coding gene in the species Homo sapiens

Clusterin is a 75-80 kDa disulfide-linked heterodimeric protein associated with the clearance of cellular debris and apoptosis. In humans, clusterin is encoded by the CLU gene on chromosome 8. CLU is a molecular chaperone responsible for aiding protein folding of secreted proteins, and its three isoforms have been differentially implicated in pro- or antiapoptotic processes. Through this function, CLU is involved in many diseases related to oxidative stress, including neurodegenerative diseases, cancers, inflammatory diseases, and aging.

<span class="mw-page-title-main">EBAG9</span> Protein-coding gene in the species Homo sapiens

Receptor-binding cancer antigen expressed on SiSo cells is a protein that in humans is encoded by the EBAG9 gene.

<span class="mw-page-title-main">MAGEA1</span> Mammalian protein found in humans

Melanoma-associated antigen 1 is a protein that in humans is encoded by the MAGEA1 gene.

<span class="mw-page-title-main">CTAG1B</span> Protein-coding gene in humans

Cancer/testis antigen 1 also known as LAGE2 or LAGE2B is a protein that in humans is encoded by the CTAG1B gene. It is most often referenced by its alias NY-ESO-1.

<span class="mw-page-title-main">MAGEA3</span> Protein-coding gene in humans

Melanoma-associated antigen 3 (MAGE-A3) is a protein that in humans is encoded by the MAGEA3 gene.

<span class="mw-page-title-main">SSX2</span> Mammalian protein found in Homo sapiens

Protein SSX2 is a protein that in humans is encoded by the SSX2 gene.

<span class="mw-page-title-main">PRAME</span>

PRAME is a protein that in humans is encoded by the PRAME gene. Five alternatively spliced transcript variants encoding the same protein have been observed for this gene.

<span class="mw-page-title-main">MAGEA2</span> Protein-coding gene in humans

Melanoma-associated antigen 2 is a protein that in humans is encoded by the MAGEA2 gene.

<span class="mw-page-title-main">MAGEC2</span> Protein-coding gene in humans

Melanoma-associated antigen C2 is a protein that in humans is encoded by the MAGEC2 gene.

<span class="mw-page-title-main">MAGED2</span> Protein-coding gene in humans

Melanoma-associated antigen D2 is a protein that in humans is encoded by the MAGED2 gene.

<span class="mw-page-title-main">MAGEB2</span> Protein-coding gene in humans

Melanoma-associated antigen B2 is a protein that in humans is encoded by the MAGEB2 gene.

<span class="mw-page-title-main">XAGE1D</span> Protein-coding gene in humans

G antigen family D member 2 is a protein that in humans is encoded by the XAGE1D gene.

<span class="mw-page-title-main">MAGEA11</span> Protein-coding gene in humans

Melanoma-associated antigen 11 is a protein that in humans is encoded by the MAGEA11 gene. It is also involved in the androgen and progesterone receptor signaling pathways.

<span class="mw-page-title-main">MAGEA12</span> Protein-coding gene in humans

Melanoma-associated antigen 12 is a protein that in humans is encoded by the MAGEA12 gene.

<span class="mw-page-title-main">SSX5</span> Protein-coding gene in the species Homo sapiens

Protein SSX5 is a protein that in humans is encoded by the SSX5 gene.

<span class="mw-page-title-main">MAGED4B</span> Protein-coding gene in humans

Melanoma-associated antigen D4 is a protein that in humans is encoded by the MAGED4B gene.

<span class="mw-page-title-main">MAGEA9</span> Protein-coding gene in humans

Melanoma-associated antigen 9 is a protein that in humans is encoded by the MAGEA9 gene.

<span class="mw-page-title-main">Melanoma antigen family a, 8</span> Protein-coding gene in the species Homo sapiens

Melanoma antigen family A, 8 is a protein that in humans is encoded by the MAGEA8 gene.

Cancer/testis (CT) antigens are a group of proteins united by their importance in development and in cancer immunotherapy. In general, expression of these proteins is restricted to male germ cells in the adult animal. However, in cancer these developmental antigens are often re-expressed and can serve as a locus of immune activation. Thus, they are often classified as tumor antigens. The expression of CT antigens in various malignancies is heterogeneous and often correlates with tumor progression. CT antigens have been described in melanoma, liver cancer, lung cancer, bladder cancer, and pediatric tumors such as neuroblastoma. Gametogenesis offers an important role for many of these antigens in the differentiation, migration, and cell division of primordial germ cells, spermatogonia spermatocytes and spermatids. Because of their tumor-restricted expression and strong in vivo immunogenicity, CT antigens are identified as ideal targets for tumor specific immunotherapeutic approaches and prompted the development of several clinical trials of CT antigens-based vaccine therapy. CT antigens have been found to have at least 70 families so far, including about 140 members, most of which are expressed during spermatogenesis. Their expression are mainly regulated by epigenetic events, specifically, DNA methylation.

<span class="mw-page-title-main">MAGEA10</span> Protein-coding gene in humans

MAGEA10 is a protein-coding gene in humans clustered at chromosomal location Xq28.

References

  1. 1 2 3 GRCh38: Ensembl release 89: ENSG00000147381 - Ensembl, May 2017
  2. "Human PubMed Reference:". National Center for Biotechnology Information, U.S. National Library of Medicine.
  3. Rogner UC, Wilke K, Steck E, Korn B, Poustka A (October 1995). "The melanoma antigen gene (MAGE) family is clustered in the chromosomal band Xq28". Genomics. 29 (3): 725–31. doi:10.1006/geno.1995.9945. PMID   8575766.
  4. 1 2 "Entrez Gene: MAGEA4 melanoma antigen family A, 4".
  5. Vital D, Ikenberg K, Moch H, Roessle M, Huber GF (June 2018). "The expression of the cancer testis antigen MAGE A4: A favorable prognostic biomarker in salivary gland carcinomas related to low tumor grading". Laryngoscope Investigative Otolaryngology. 3 (3): 182–190. doi:10.1002/lio2.160. PMC   6057220 . PMID   30062133.
  6. Yakirevich E, Sabo E, Lavie O, Mazareb S, Spagnoli GC, Resnick MB (December 2003). "Expression of the MAGE-A4 and NY-ESO-1 cancer-testis antigens in serous ovarian neoplasms". Clinical Cancer Research. 9 (17): 6453–60. PMID   14695148.
  7. "Specific Peptide-Enhanced Affinity Receptor MAGE-A4 T Cells for Synovial Sarcoma". www.healio.com. Retrieved 2021-07-02.
  8. Hong DS, Butler MO, Johnson M, Olszanski AJ, Norry E, Van Winkle E, et al. (October 2018). "Initial safety assessment of MAGE-A4 SPEAR T-cells". Annals of Oncology. 29: viii412. doi: 10.1093/annonc/mdy288.029 .

Further reading